Clinical data | |
---|---|
Other names | Morphine dinicotinate, 3,6-dinicotinoylmorphine |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, Intravenous, Rectal |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.326 |
Chemical and physical data | |
Formula | C29H25N3O5 |
Molar mass | 495.535 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Nicomorphine (Vilan, Subellan, Gevilan, MorZet) is the 3,6-dinicotinate ester of morphine. It is a strong opioid agonist analgesic two to three times as potent as morphine with a side effect profile similar to that of dihydromorphine, morphine, and diamorphine.
Nicomorphine was first synthesized in 1904 and was patented as Vilan by Lannacher Heilmittel G.m.b.H. of Austria in 1957.